within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A07X_OtherAntidiarrheals.A07XA02_Ceratonia;

model Ceratonia
  extends Pharmacolibrary.Drugs.ATC.A.A07XA02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A07XA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Ceratonia, commonly known as carob, refers to preparations from the seeds or pods of Ceratonia siliqua. It has been used as a traditional antidiarrheal agent in adults and children, particularly in cases of mild to moderate diarrhea. Ceratonia is not a conventional pharmaceutical drug and is not assigned to widely recognized approved drug use today, but carob preparations are sometimes used in nutraceuticals and in food supplements.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic models or parameters for ceratonia/carob exist in the current biomedical literature, as its mechanism is largely local (adsorptive action in the gut) and systemic absorption is not significant.</p><h4>References</h4><ol><li><p>Xu, X, et al., &amp; Nel, AE (2023). Use of a Liver-Targeting Immune-Tolerogenic mRNA Lipid Nanoparticle Platform to Treat Peanut-Induced Anaphylaxis by Single- and Multiple-Epitope Nucleotide Sequence Delivery. <i>ACS nano</i> 17(5) 4942–4957. DOI:<a href=&quot;https://doi.org/10.1021/acsnano.2c12420&quot;>10.1021/acsnano.2c12420</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36853930/&quot;>https://pubmed.ncbi.nlm.nih.gov/36853930</a></p></li><li><p>Navarro, JA, et al., &amp; Fonseca, FR (2022). Pharmacokinetics and Endocrine Effects of an Oral Dose of D-Pinitol in Human Fasting Healthy Volunteers. <i>Nutrients</i> 14(19) –. DOI:<a href=&quot;https://doi.org/10.3390/nu14194094&quot;>10.3390/nu14194094</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36235746/&quot;>https://pubmed.ncbi.nlm.nih.gov/36235746</a></p></li><li><p>Tang, Y, et al., &amp; Wang, S (2023). Pharmacological Activities and Pharmacokinetics of Glycycoumarin. <i>Revista brasileira de farmacognosia : orgao oficial da Sociedade Brasileira de Farmacognosia</i> 33(3) 471–483. DOI:<a href=&quot;https://doi.org/10.1007/s43450-022-00342-x&quot;>10.1007/s43450-022-00342-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36567915/&quot;>https://pubmed.ncbi.nlm.nih.gov/36567915</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Ceratonia;
